| 1 |
coronavirus disease 2019
(10278 times)
|
Medicine
(1028 times)
|
SARS-CoV-2 (2448 times)
ACE2 (280 times)
CI (272 times)
|
0 Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations.
|
| 2 |
coronavirus 2019 disease
(49 times)
|
Medicine
(6 times)
|
SARS-CoV-2 (9 times)
CI (3 times)
OR (3 times)
|
2020 Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
|
| 3 |
SARS-CoV-2, coronavirus disease 2019
(27 times)
|
Medicine
(6 times)
|
SARS-CoV-2 (8 times)
WHO (3 times)
MERS (2 times)
|
2020 Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens.
|
| 4 |
CoV disease 2019
(10 times)
|
Biology
(3 times)
|
SARS-CoV-2 (6 times)
ACE2 (2 times)
CoV (2 times)
|
2020 Zoonotic origins of human coronaviruses.
|
| 5 |
coronavirus identified in 2019
(9 times)
|
Education
(7 times)
|
VGSC (1 time)
|
2020 Letter to the Editor "COVID-19 and Neurosurgical Education in Africa: Making Lemonade from Lemons".
|
| 6 |
coronavirus disease 2019 pandemic
(7 times)
|
Vascular Diseases
(1 time)
|
AAAA (1 time)
ArLAR (1 time)
CRD (1 time)
|
2020 Massive cutback in orthopaedic healthcare services due to the COVID-19 pandemic.
|
| 7 |
Coronavirus epidemic 2019
(6 times)
|
Public Health
(1 time)
|
---
|
2020 Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CLpro of 2019-nCoV than monomeric anthocyanins: A structural-relationship activity study with 10 anthocyanins using in-silico approaches.
|
| 8 |
2019-coronavirus disease
(4 times)
|
Diabetes Mellitus
(1 time)
|
SARS-CoV-2 (1 time)
SUD (1 time)
|
2020 Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression.
|
| 9 |
coronavirus disease
(4 times)
|
Toxicology
(1 time)
|
BRAT (1 time)
Lu-PoCUS (1 time)
Q-Q (1 time)
|
2020 [COVID-19 - More Lung Pocus and Sparing Use of Stethoscope, Chest X-Ray and Lung CT].
|
| 10 |
cases of the coronavirus-induced disease-2019
(2 times)
|
Cardiovascular Diseases
(1 time)
|
STEMI (1 time)
|
2020 Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.
|
| 11 |
cause of coronavirus 2019 disease
(2 times)
|
Biomedical Research
(1 time)
|
SARS (1 time)
|
2020 Olfactory Dysfunction in the COVID-19 Outbreak.
|
| 12 |
Clusters of 2019 coronavirus disease
(2 times)
|
Veterinary Medicine
(1 time)
|
---
|
2020 Clinical and imaging features of COVID-19.
|
| 13 |
coronavirus disease identified in 2019
(2 times)
|
Neurosurgery
(1 time)
|
DC (1 time)
HV (1 time)
|
2020 An Australian Response to the COVID-19 Pandemic and Its Implications on the Practice of Neurosurgery.
|
| 14 |
current outbreak of coronavirus disease-2019
(2 times)
|
Science
(1 time)
|
SARS-CoV-2 (1 time)
|
2020 Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.
|
| 15 |
SARS-CoV-2 disease 2019
(2 times)
|
Allergy and Immunology
(1 time)
|
PE (1 time)
VTE (1 time)
|
2020 Anticoagulation Practice Patterns in COVID-19: A Global Survey.
|
| 16 |
caused by this agent aquired the name “coronavirus disease 2019
(1 time)
|
History of Medicine
(1 time)
|
RT-PCR (1 time)
SARS-CoV-2 (1 time)
WHO (1 time)
|
2020 Diagnostic consideration and bedside estimation of the prognosis in COVID-19 patients
|
| 17 |
chest manifestations ofcoronavirus disease 2019
(1 time)
|
|
CT-SS (1 time)
GGOs (1 time)
HRCT (1 time)
|
2020 An Analysis of High-Resolution Computed Tomography Chest Manifestations of COVID-19 Patients in Pakistan.
|
| 18 |
contagious and deadlycoronavirus disease 2019
(1 time)
|
Geriatrics
(1 time)
|
---
|
2020 Elderly care in the time of coronavirus: Perceptions and experiences of care home staff in Pakistan.
|
| 19 |
continuing outbreak of thecoronavirus disease 2019
(1 time)
|
Epidemiology
(1 time)
|
---
|
2020 Preparing for the coming transnational cancer crisis amid the COVID-19 pandemic.
|
| 20 |
coronavirus 2019 disease infection
(1 time)
|
Cardiovascular Diseases
(1 time)
|
---
|
2020 Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.
|
| 21 |
coronavirus 2019 respiratory disease
(1 time)
|
Hematology
(1 time)
|
---
|
2020 Intra-articular injections in people with haemophilia in the COVID-19 era.
|
| 22 |
Coronavirus Disease - 2019-nCoV
(1 time)
|
Nursing
(1 time)
|
LRTIs (1 time)
WHO (1 time)
|
2020 Coronavirus Disease - 2019-nCoV (COVID-19).
|
| 23 |
Coronavirus Disease Pandemic 2019
(1 time)
|
Medicine
(1 time)
|
SARS-CoV-2 (1 time)
|
2020 [Epidemiology and control of COVID-19].
|
| 24 |
coronavirus disease that emerged in 2019
(1 time)
|
Psychology
(1 time)
|
---
|
2020 Women's leadership is associated with fewer deaths during the COVID-19 crisis: Quantitative and qualitative analyses of United States governors.
|
| 25 |
Coronavirus emerged in December of 2019
(1 time)
|
Statistics as Topic
(1 time)
|
---
|
2020 Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus.
|
| 26 |
coronavirus or coronavirus disease 2019
(1 time)
|
Pharmacology
(1 time)
|
SARS-CoV-2 (1 time)
WHO (1 time)
|
2020 Pharmacological treatments of COVID-19.
|
| 27 |
coronavirus that started in late 2019
(1 time)
|
Pediatrics
(1 time)
|
SARS-CoV-2 (1 time)
|
2020 Why is COVID-19 so mild in children?
|
| 28 |
coronavirus was identified in December 2019
(1 time)
|
Medicine
(1 time)
|
ARDS (1 time)
ICU (1 time)
|
2020 Why tocilizumab could be an effective treatment for severe COVID-19?
|
| 29 |
coronavirus-associated disease that emerged in December 2019
(1 time)
|
Biochemistry
(1 time)
|
SARS-CoV (1 time)
|
2020 Stability of RNA sequences derived from the coronavirus genome in human cells.
|
| 30 |
coronavirus-associated disease-2019
(1 time)
|
Vascular Diseases
(1 time)
|
ACS (1 time)
SHD (1 time)
|
2020 Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic.
|
| 31 |
Coverage During the Coronavirus 2019
(1 time)
|
Neurosurgery
(1 time)
|
---
|
2020 Letter to the Editor 'Neurosurgical Service Coverage During the COVID-19 Pandemic: The 'Battle Plan' at the University of South of Florida Affiliate Hospitals'.
|
| 32 |
covid disease 19
(1 time)
|
Medicine
(1 time)
|
---
|
2020 [Coronavirus, emerging viruses].
|
| 33 |
COVIDstable patients
(1 time)
|
Critical Care
(1 time)
|
CAPICU patients (1 time)
PKM2 (1 time)
|
2020 Characterization of the Inflammatory Response to Severe COVID-19 Illness.
|
| 34 |
currently ongoing coronavirus disease 2019
(1 time)
|
|
---
|
2020 Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.
|
| 35 |
disease-Coronavirus disease 2019
(1 time)
|
Cell Biology
(1 time)
|
BSL-3 (1 time)
|
2020 Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens.
|
| 36 |
SARS-coronavirus 2 disease initially reported in December 2019 in China
(1 time)
|
Medicine
(1 time)
|
---
|
2020 [COVID-19 : Intensive care management].
|
| 37 |
Syndrome-Coronavirus Disease 2019
(1 time)
|
Environmental Health
(1 time)
|
AOD (1 time)
|
2020 The dark cloud with a silver lining: Assessing the impact of the SARS COVID-19 pandemic on the global environment.
|
A Search Service for Abbreviation / Long Form